Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.


You May Also Like

Related Analysis
  1. Personal Finance

    How Youtube Makes Money Off Videos

  2. Investing

    How The Video Game Industry Works

  3. Stock Analysis

    Apple's Critical Acquisition, Google-Tesla Merger Debunked And More Weekly Tech Highlights

  4. Investing

    Facebook Vs. Weibo

  5. Stock Analysis

    Apple's Secret Plan To Change Augmented Reality Is Finally Emerging

Trading Center